InhaleRx Limited (AU:IRX) has released an update.
InhaleRx Limited has disclosed a change in the interests of Director Sean Williams through an Appendix 3Y filing, revealing an acquisition of 2,000,000 unlisted options exercisable at $0.15 each, set to expire on 03/06/2027. These options were issued as part of the company’s Incentive Entitlements Plan, approved by shareholders at the Annual General Meeting on 30 May 2024. Post-acquisition, Williams’s interest includes 200,000 ordinary shares and a total of 6,000,000 unlisted options across various expiry dates and exercise prices.
For further insights into AU:IRX stock, check out TipRanks’ Stock Analysis page.